CN103784461A - 一种动物用恩诺沙星软膏的制备方法 - Google Patents

一种动物用恩诺沙星软膏的制备方法 Download PDF

Info

Publication number
CN103784461A
CN103784461A CN201210432851.4A CN201210432851A CN103784461A CN 103784461 A CN103784461 A CN 103784461A CN 201210432851 A CN201210432851 A CN 201210432851A CN 103784461 A CN103784461 A CN 103784461A
Authority
CN
China
Prior art keywords
enrofloxacin
ointment
preparation
animals
animal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201210432851.4A
Other languages
English (en)
Inventor
郝智慧
刘元元
王艳玲
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
QINGDAO CONLINENT ANIMAL PHARMACEUTICAL CO Ltd
Original Assignee
QINGDAO CONLINENT ANIMAL PHARMACEUTICAL CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by QINGDAO CONLINENT ANIMAL PHARMACEUTICAL CO Ltd filed Critical QINGDAO CONLINENT ANIMAL PHARMACEUTICAL CO Ltd
Priority to CN201210432851.4A priority Critical patent/CN103784461A/zh
Publication of CN103784461A publication Critical patent/CN103784461A/zh
Pending legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

本发明公开了一种动物用恩诺沙星软膏的制备方法。本发明主要含有恩诺沙星10%-30%,地塞米松磷酸钠0.05%-0.25%,甘油1%-10%,冰醋酸1%-2%,凡士林至全量。本发明主要用于对动物(如犬、猫、兔子、猎、狐狸、格等)耳瞒病的预防或治疗,给药方式为涂抹于耳道内,具有使用方便、成本较低、毒副反应小等优点。

Description

一种动物用恩诺沙星软膏的制备方法
技术领域
       本发明涉及动物用药物,具体地说涉及一种动物用恩诺沙星软膏的制备方法。
背景技术
       耳螨病是由疥螨或痒螨寄生于动物耳内引起的一种寄生虫病,是一种局部寄生虫。耳螨病是宠物(如犬、猫等)、毛皮动物(如狐狸、貂、貉等)、兔子和猪等动物中常见的寄生虫病。据调查,犬、猫耳螨的感染率在20% 以上,兔子的耳螨感染率在50% 以上。耳螨严重危害动物健康,影响宠物的习性和行为,影响经济动物的生产性能,甚至造成死亡。目前常用动物耳螨的制剂主要是含大环内酯类抗寄生虫药物的注射剂(如伊维菌素注射剂)。注射剂为全身给药,存在给药量大、成本高、毒副反应大、使用不方便等缺点。研制一种耳部给药(为局部给药)的药物制剂来防治动物耳螨可以降低给药量,降低用药成本,减少全身给药引起的毒副反应。此外,与全身用药相比,耳部给药更为方便。
发明内容
       本发明的目的是提供一种含有恩诺沙星的药用组合物,以及在制备兽用杀耳螨药物上的应用,该药物用于动物(如犬、猫、兔子、猪、狐狸、貉等)耳螨病的预防或治疗,给药部位为耳道给药,为局部给药,具有使用方便、成本较低和毒副反应小等优点。
所述的一种动物用恩诺沙星软膏的制备方法,其特征为主要含有恩诺沙星10%-30%,地塞米松磷酸钠0.05%-0.25%,甘油1%-10%,冰醋酸1%-2%,凡士林至全量。
所述的一种动物用恩诺沙星软膏的制备方法,其特征为,将处方量恩诺沙星、地塞米松磷酸钠溶于处方量甘油、冰乙酸,然后用凡士林定容即得。
具体实施方式
   
   处方:  恩诺沙星  10g
           地塞米松磷酸钠0.2g
           甘油     10g
           冰醋酸   2g
           凡士林 至 100g
  制备方法:将处方量恩诺沙星10g、地塞米松磷酸钠0.1g溶于10g甘油、2g冰乙酸,充分溶解后,用凡士林定量至100g,充分搅拌即得。

Claims (2)

1.一种动物用恩诺沙星软膏的制备方法,其特征为主要含有恩诺沙星10%-30%,地塞米松磷酸钠0.05%-0.25%,甘油1%-10%,冰醋酸1%-2%,凡士林至全量。
2.根据权利要求1所述的一种动物用恩诺沙星软膏的制备方法,其特征为,将处方量恩诺沙星、地塞米松磷酸钠溶于处方量甘油、冰乙酸,然后用凡士林定量,充分搅拌即得。
CN201210432851.4A 2012-11-03 2012-11-03 一种动物用恩诺沙星软膏的制备方法 Pending CN103784461A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201210432851.4A CN103784461A (zh) 2012-11-03 2012-11-03 一种动物用恩诺沙星软膏的制备方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210432851.4A CN103784461A (zh) 2012-11-03 2012-11-03 一种动物用恩诺沙星软膏的制备方法

Publications (1)

Publication Number Publication Date
CN103784461A true CN103784461A (zh) 2014-05-14

Family

ID=50660798

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201210432851.4A Pending CN103784461A (zh) 2012-11-03 2012-11-03 一种动物用恩诺沙星软膏的制备方法

Country Status (1)

Country Link
CN (1) CN103784461A (zh)

Similar Documents

Publication Publication Date Title
Randhawa Cow urine distillate as bioenhancer
KR101295228B1 (ko) 축사 및 양계 소독용 살충제 조성물 및 이의 제조방법
AR042537A1 (es) Composiciones farmaceuticas dispersables que contienen antibacterianos para animales productores de leche
CN102415991B (zh) 恩诺沙星长效注射液及其制备方法
EP3566695B1 (en) Treatment of coccidiosis with intramuscular triazine compositions
CN102772363B (zh) 一种含泊那珠利的溶液剂及其制备方法
CN104095871A (zh) 一种含盐酸林可霉素与硫酸大观霉素的兽用注射液
CN104069070A (zh) 一种具有高效杀菌消毒作用的聚维酮碘粉剂及其制备方法
Drake et al. Treatment success in three Andean bears (Tremarctos ornatus) with alopecia syndrome using oclacitinib maleate (Apoquel®)
AU2011210267A1 (en) Topical antiparasitic formulations
EP2982369A1 (en) Preparation for treating equine inflammation
CN103830251A (zh) 一种动物用氧氟沙星滴耳液的制备
CN103784461A (zh) 一种动物用恩诺沙星软膏的制备方法
US20210220335A1 (en) Nitroimidazole formulations
CN114939104B (zh) 一种用于减轻猫应激的外用透皮制剂、制备方法及应用
KR101400791B1 (ko) 동물용 복합 기능성 항생제 조성물
Plant et al. Efficacy of topical eprinomectin in the treatment of Chorioptes sp. infestation in alpacas and llamas
CN110721152B (zh) 一种治疗动物皮肤寄生虫、真菌感染的缓释组合物
RU2442573C1 (ru) Способ лечения дизентерии свиней
CN105168121A (zh) 兽用复方三氮脒注射液及其制备方法
CN112336706A (zh) 一种兽用双甲脒溶液增效剂及其制备方法
CN109464390A (zh) 复方氯菊酯组合物及其制备方法
Oliveira et al. Oral administration of an anti-inflammatory does not compromise the efficacy of intra-testicular injection of zinc gluconate as a contraceptive for dogs
CN102908311B (zh) 一种托芬那酸注射液及其制备方法和应用
CN104721196A (zh) 一种兽用恩诺沙星、磺胺嘧啶银的兽用注射液制备方法及其应用

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20140514